tiprankstipranks
Advertisement
Advertisement
Medacta Group price target raised to CHF 182 from CHF 175 at Berenberg
PremiumThe FlyMedacta Group price target raised to CHF 182 from CHF 175 at Berenberg
3M ago
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
Premium
Company Announcements
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
6M ago
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
Premium
Company Announcements
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
6M ago
Medacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
PremiumCompany AnnouncementsMedacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
6M ago
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
Premium
Company Announcements
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
6M ago
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
Premium
Company Announcements
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
6M ago
Medacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
PremiumCompany AnnouncementsMedacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
7M ago
Medacta Group downgraded to Neutral from Buy at UBS
Premium
The Fly
Medacta Group downgraded to Neutral from Buy at UBS
8M ago
Medacta Group price target raised to CHF 159 from CHF 146 at Morgan Stanley
Premium
The Fly
Medacta Group price target raised to CHF 159 from CHF 146 at Morgan Stanley
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100